Another World First from ADP Diagnostics coming soon................
Whole Blood Glucose Controls for Glucometers with 3 month stability. Never seen before with this level of stability, this is a true innovation in Glucometer QC. Clinical trials are starting soon as a prequel to our product launch. Designed to meet ISO 15189 requirements for quality controlling glucometers across the world. Replace the glucose solution with a true whole blood alternative!
Serum Indices Quality Control family of products continues to grow and improve. This is a unique product to ADP Diagnostics with no other manufacturer worldwide offering a similar specification control.
Our Mission, to be the world's leading manufacturer of bespoke and esoteric Quality Control Products
A WORLD FIRST, now available for Roche and Abbott clinical Platforms.
( Beckman and Siemens coming soon)
QCHIL/A, QCHIL/R. Ensure accurate monitoring of patient samples for Serum Indices by running this QC daily. Haemolysis, Icterus and Lipaemia affect clinical chemistry analytes to a greater or lesser degree depending on levels present in the patient sample. Our combined 3 Level Serum Indices Controls provide confidence in your analysers' results
Pack Size 4 x 3 x 5ml
Anti Mullerian Hormone 3rd Party Quality Controls
QCAMHR. This is our first kit format for independent control of your AMH assay, whether for the Roche Cobas, Beckman Access automated System, or an Elisa Format.
Developed in conjunction with the Royal Victoria Hospital in Belfast, N. Ireland. The levels have been chosen to reflect critical clinical cut-off values around 12 pmol/L, a mid assay and an elevated level of 90 pmol/L, to check the linearity of the assay.
Stored frozen, defrosted it is stable for 7 days. The kit contains 2 bottles of each level, 3 levels, and 2 mls per vial ( 2 x 3 x 2ml)
Available to order now
PSA Ultra Low Quality Control
QCPSA/L Manufactured in response to many requests for a low level control to keep pace with ever increasing sensitivities of assays, and publications and recommendations for low level cut offs post Prostatectomy;
"A low level or undetectable PSA level is defined as less than or equal to 0.06ng/ml or 0.02ng/ml by the American Society for Theraputic and Oncology consensus Panel. As defined by the Institution, it is agreed that a 6 to 12 months 'undectable PSA' is a prediction of disease free survival 'DFS'. Therefore an ultrasenstive assay is beneficial."
With a target value of 0.06 ng/ml (Roche Cobas), our kit reflects the guidelines.
Stored @ 2-8 C, open vial stability is 14 days. The kit size is 10 x 1ml.
Available to order now.
01 January 2019
2018 was a fabulous year for ADP Diagnostics. New innovative products coming on stream, like Ultra Low PSA Control, Supplying Prop Bio Qual with 3 distributions of Custom Serum Indices Controls, and continued supply of QC to SNEQAS in Slovenia. We are all looking forward to a great 2019
23 March 2018
Simon Boyd of PWC
I enjoyed interviewing Greg Simpson , as he discussed his exporting journey for his company ADP Diagnostics. Its refreshing that even small companies can make a difference around the world. #5daysof, #trade, #export, #LeadingNI @PwC_NI
